stockrowFulgent Genetics, Inc. (FLGT) vs OPKO Health, Inc. (OPK)
- Fulgent Genetics, Inc. FLGT 18.66 −5.18%
- OPKO Health, Inc. OPK 1.75 −1.13%
Fulgent Genetics, Inc. and OPKO Health, Inc. are both Diagnostics & Research companies. OPKO Health, Inc. is the larger, with a market value of $1.3B against $513.4M — 2.6× the size. Fulgent Genetics, Inc. grew revenue faster over the last twelve months: 4.67% against −21.9%. Fulgent Genetics, Inc. has the higher net margin (−27.5% vs −29.5%) and the lower return on invested capital (−8.22% vs −6.72%). Across the 18 metrics below, Fulgent Genetics, Inc. leads on 12 and OPKO Health, Inc. on 6.
Valuation
Profitability
| Metric | FLGT | OPK | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.82% | 46.22% | 48.32% |
| Operating margin | (39.20%) | (25.46%) | (5.68%) |
| Net margin | (27.53%) | (29.51%) | (4.10%) |
| Free cash flow margin | 4.37% | (26.91%) | 0.00% |
| Return on equity | (8.64%) | (12.23%) | 0.00% |
| Return on assets | (7.93%) | (7.64%) | (6.05%) |
| Return on invested capital | (8.22%) | (6.72%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack